Equatorial Guinea vs Papua New Guinea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology

Equatorial Guinea
2.0%
in 2024
Papua New Guinea
2.5%
in 2024
Equatorial Guinea rank
14th
Papua New Guinea rank
11th

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time

  • Equatorial Guinea
  • Papua New Guinea
00.511.522.5201520192024

How they compare

Papua New Guinea currently reports 2.5% against 2.0% in Equatorial Guinea, a difference of 0.5%.

That makes Papua New Guinea's figure about 1.2 times Equatorial Guinea's.

The two have swapped places 1 time across 10 shared years of data; in 2015 it was Equatorial Guinea ahead.

Equatorial Guinea ranks 14th and Papua New Guinea ranks 11th of 246 countries.

Across the 2 decades both report, Equatorial Guinea averaged higher in 1 and Papua New Guinea in 1.

Head to head by decade

Decade Equatorial Guinea Papua New Guinea Difference Ahead
2010s 2.3% 2.0% 0.3% Equatorial Guinea
2020s 2.1% 2.4% 0.3% Papua New Guinea

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Equatorial Guinea or Papua New Guinea?
Papua New Guinea, at 2.5% against 2.0% in Equatorial Guinea as of 2024.
What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Equatorial Guinea and Papua New Guinea?
0.5%, with Papua New Guinea ahead.
How many years of comparable data are there for Equatorial Guinea and Papua New Guinea?
10 years are reported by both, from 2015 to 2024.
How do Equatorial Guinea and Papua New Guinea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Equatorial Guinea ranks 14th and Papua New Guinea ranks 11th of 246 countries.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Equatorial Guinea vs Papua New Guinea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 09 September 2026, from https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/equatorial-guinea/papua-new-guinea/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/equatorial-guinea/papua-new-guinea/">Equatorial Guinea vs Papua New Guinea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Unit
%
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
250 places, 2,500 data points, 2015–2024
Last refreshed